COVID-19 and Colorectal Cancer Get The Facts

Blog banner Blog banner

Psychosocial support for patients with cancer during COVID-19

The COVID-19 pandemic has presented countless new challenges in cancer care. As healthcare providers strive to treat patients as effectively as possible while minimizing their risk of infection, there are also important psychosocial needs of the moment to take into consideration. Psychosocial care is a whole-person approach to ...



The COVID-19 pandemic situation is constantly evolving. Canada is slowly reopening, with many cities and municipalities enforcing mask requirements and social bubbles to reduce the ongoing spread. Colorectal Cancer Canada (CCC) aims to support colorectal cancer patients, family/friends and caregivers through this constantly evol...


CRC with peritoneal metastases: CRS-HIPEC refinements

Results of several new studies provide important perspectives on the use of hyperthermic intraperitoneal chemotherapy (HIPEC), a specialized treatment for cancers that have spread to the inner lining of the abdomen (peritoneal metastases). HIPEC is typically used in combination with cytoreductive surgery (CRS), an approach that ...


Four actionable targets for metastatic colorectal cancer

In the past two years, findings from important clinical trials are shaping a new approach to treating different subgroups of patients with metastatic colorectal cancer (mCRC). Today, screening patients for biomarkers such as microsatellite instability status, BRAFV600E, HER2 and neurotrophic tyrosine receptor kinase (NTRK) is un...


Patient Group Pathway Model to Accessing Cancer Clinical Trials and RWE Conference

Hold the Date! On behalf of Colorectal Cancer Canada (CCC), you are cordially invited to attend the Patient Group Pathway Model to Accessing Cancer Clinical Trials and Real World Evidence Methodologies Conference with a special focus on precision medicine. Conference: October 21, 2020 (9:00 am - 4:00 pm) Location: THE EVENT...